ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,478Medicare Part D Prescriptions Filled, Including Refills

Rank: 220 out of 780

$597K Total Retail Price of All Prescriptions

Rank: 230 out of 780

424 Patients Receiving at Least One Drug in Part D
57%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 424 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

35% of this provider’s 424 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 6,968 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 643 367 1 2
HYDROCODONE-ACETAMINOPHEN 611 222 S3 2 1
AMLODIPINE BESYLATE 558 413 3 4
HYDROCHLOROTHIAZIDE 536 289 4 10
OMEPRAZOLE 460 298 5 3
LEVOTHYROXINE SODIUM 401 290 6 5
METFORMIN HCL 344 164 7 8
LISINOPRIL 323 135 8 6
METOPROLOL SUCCINATE 291 210 9 20
ZOLPIDEM TARTRATE 280 108 10 17
LOSARTAN POTASSIUM 278 176 11 18
POTASSIUM CHLORIDE 224 158 12 11
LOSARTAN-HYDROCHLOROTHIAZIDE 176 124 13 33
ATENOLOL 176 94 13 21
NEXIUM 176 75 13 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 175 62 16 26
CARVEDILOL 163 104 17 14
GLIPIZIDE 163 103 17 74
FUROSEMIDE 161 137 19 7
CRESTOR 156 114 20 32
SYNTHROID 148 93 21 77
GABAPENTIN 133 40 22 13
VERAPAMIL ER 130 62 23 78
SPIRIVA 129 57 24 72
CYMBALTA 115 30 25 51
HYDRALAZINE HCL 107 85 26 54
TRAMADOL HCL 106 79 27 15
CYCLOBENZAPRINE HCL 103 25 R 28 42
CLOPIDOGREL 102 68 29 34
ALENDRONATE SODIUM 99 69 30 44
ATORVASTATIN CALCIUM 96 65 31 12
METFORMIN HCL ER 95 63 32 43
LOVASTATIN 91 76 33 47
CITALOPRAM HBR 87 27 34 23
ALLOPURINOL 80 59 35 29
CLONIDINE HCL 79 34 36 28
PRAVASTATIN SODIUM 76 37 37 9
PLAVIX 70 39 38 45
MELOXICAM 68 27 39 16
ENALAPRIL MALEATE 65 53 40 64
METOPROLOL TARTRATE 65 34 40 19
LYRICA 63 27 42 52
CARBIDOPA-LEVODOPA 61 39 43 124
AMITRIPTYLINE HCL 59 11 R 44 48
BENAZEPRIL HCL 56 31 45 59
ADVAIR DISKUS 53 25 46 68
TAMSULOSIN HCL 52 29 47 36
SINGULAIR 52 23 47 73
LOVAZA 51 14 49 183
BYSTOLIC 51 49 49 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 4, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.